These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 11839382)
1. Inhibiting effects on the induction of cytotoxic T lymphocytes by dendritic cells pulsed with lysates from acute myeloid leukemia blasts. Schui DK; Singh L; Schneider B; Knau A; Hoelzer D; Weidmann E Leuk Res; 2002 Apr; 26(4):383-9. PubMed ID: 11839382 [TBL] [Abstract][Full Text] [Related]
2. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin. Spisek R; Chevallier P; Morineau N; Milpied N; Avet-Loiseau H; Harousseau JL; Meflah K; Gregoire M Cancer Res; 2002 May; 62(10):2861-8. PubMed ID: 12019165 [TBL] [Abstract][Full Text] [Related]
3. [The T cells activated by dendritic cells derived from AML cells: a study of their cytotoxic effect on autologous AML cells]. Xiang B; Li SF; Zhou J; Mao YQ; Yang YM; Liu T Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):784-7. PubMed ID: 15573754 [TBL] [Abstract][Full Text] [Related]
4. Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia. Harrison BD; Adams JA; Briggs M; Brereton ML; Yin JA Blood; 2001 May; 97(9):2764-71. PubMed ID: 11313269 [TBL] [Abstract][Full Text] [Related]
6. Presentation of tumor antigens by phagocytic dendritic cell clusters generated from human CD34+ hematopoietic progenitor cells: induction of autologous cytotoxic T lymphocytes against leukemic cells in acute myelogenous leukemia patients. Fujii S; Fujimoto K; Shimizu K; Ezaki T; Kawano F; Takatsuki K; Kawakita M; Matsuno K Cancer Res; 1999 May; 59(9):2150-8. PubMed ID: 10232602 [TBL] [Abstract][Full Text] [Related]
7. AML-loaded DC generate Th1-type cellular immune responses in vitro. Xing D; Decker WK; Li S; Robinson SN; Yang H; Segal H; O'Connor S; Yao X; Komanduri KV; McMannis JD; Jones RB; de Lima M; Champlin RE; Shpall EJ Cytotherapy; 2006; 8(2):95-104. PubMed ID: 16698683 [TBL] [Abstract][Full Text] [Related]
8. Dendritic cells (DCs) can be successfully generated from leukemic blasts in individual patients with AML or MDS: an evaluation of different methods. Kremser A; Dressig J; Grabrucker C; Liepert A; Kroell T; Scholl N; Schmid C; Tischer J; Kufner S; Salih H; Kolb HJ; Schmetzer H J Immunother; 2010; 33(2):185-99. PubMed ID: 20139775 [TBL] [Abstract][Full Text] [Related]
9. Reconstitution of CD40 and CD80 in dendritic cells generated from blasts of patients with acute myeloid leukemia. Li L; Schmitt A; Reinhardt P; Greiner J; Ringhoffer M; Vaida B; Bommer M; Vollmer M; Wiesneth M; Döhner H; Schmitt M Cancer Immun; 2003 Jul; 3():8. PubMed ID: 12862419 [TBL] [Abstract][Full Text] [Related]
10. Employing the immunological synapse in AML: development of leukemic dendritic cells for active specific immunization. Houtenbos I; Westers TM; Ossenkoppele GJ; van de Loosdrecht AA Immunobiology; 2005; 210(2-4):249-57. PubMed ID: 16164032 [TBL] [Abstract][Full Text] [Related]
11. Sequential modulation of growth factors: a novel strategy for adoptive immunotherapy of acute myeloid leukemia. Zhong RK; Rassenti LZ; Kipps TJ; Chen J; Law P; Yu JF; Ball ED Biol Blood Marrow Transplant; 2002; 8(10):557-68. PubMed ID: 12434951 [TBL] [Abstract][Full Text] [Related]
12. Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells. Schöttker B; Schmidt-Wolf IG Ger Med Sci; 2011; 9():Doc18. PubMed ID: 21863132 [TBL] [Abstract][Full Text] [Related]
13. Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in 'DC-culture-media' shifts correlations of released chemokines with antileukemic T-cell reactions. Merle M; Fischbacher D; Liepert A; Grabrucker C; Kroell T; Kremser A; Dreyssig J; Freudenreich M; Schuster F; Borkhardt A; Kraemer D; Koehne CH; Kolb HJ; Schmid C; Schmetzer HM Immunobiology; 2021 May; 226(3):152088. PubMed ID: 33838552 [TBL] [Abstract][Full Text] [Related]
14. Leukemic dendritic cells: potential for therapy and insights towards immune escape by leukemic blasts. Mohty M; Olive D; Gaugler B Leukemia; 2002 Nov; 16(11):2197-204. PubMed ID: 12399962 [TBL] [Abstract][Full Text] [Related]
15. Impaired antigen presentation in neoplasia: basic mechanisms and implications for acute myeloid leukemia. van Luijn MM; van den Ancker W; Chamuleau ME; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA Immunotherapy; 2010 Jan; 2(1):85-97. PubMed ID: 20635891 [TBL] [Abstract][Full Text] [Related]
16. [T-cell immunity against autologous leukemic cell mediated by in vitro bone marrow-derived dendritic cell from patients with acute myeloid leukemia in complete remission]. He X; You S; Bian S Zhonghua Xue Ye Xue Za Zhi; 2001 Dec; 22(12):629-32. PubMed ID: 16200709 [TBL] [Abstract][Full Text] [Related]
17. Ex vivo induction of anti-leukemia cytotoxic T cell effect by dendritic cells from human umbilical cord blood cell origin. Tan H; Zeng LJ; Ye X Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):472-8. PubMed ID: 15972145 [TBL] [Abstract][Full Text] [Related]
18. Activation of autologous leukemia-specific T cells in acute myeloid leukemia: monocyte-derived dendritic cells cocultured with leukemic blasts compared with leukemia-derived dendritic cells. Draube A; Beyer M; Wolf J Eur J Haematol; 2008 Oct; 81(4):281-8. PubMed ID: 18573171 [TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts. Li L; Giannopoulos K; Reinhardt P; Tabarkiewicz J; Schmitt A; Greiner J; Rolinski J; Hus I; Dmoszynska A; Wiesneth M; Schmitt M Int J Oncol; 2006 Apr; 28(4):855-61. PubMed ID: 16525634 [TBL] [Abstract][Full Text] [Related]
20. Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia. Woiciechowsky A; Regn S; Kolb HJ; Roskrow M Leukemia; 2001 Feb; 15(2):246-55. PubMed ID: 11236940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]